---
title: "New Zealand progress toward eliminating HIV by 2030: trends, gaps, and priorities"
id: "pubmed-43056630"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43056630"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43056630/"
doi: "10.26635/6965.7595"
published_at: "2026-11-20T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# New Zealand progress toward eliminating HIV by 2030: trends, gaps, and priorities
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43056630
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43056630/)
- **DOI:** [10.26635/6965.7595](https://doi.org/10.26635%2F6965.7595)
- **Published At:** 2026-11-20T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Aotearoa New Zealand has tools and a strategic framework to end **HIV** transmission; the article assesses progress against the Government's HIV action plan 2023–2030. - Investigators reported a marked decline in new diagnoses among **GBM** (gay, bisexual and other men who have sex with men), concurrent with increased prevention behaviours. - Surveillance data indicated very low HIV diagnoses in other key populations, including sex workers and people who inject drugs. - The authors noted persistent static diagnosis rates among Māori and Pacific **GBM**, indicating uneven distribution of prevention benefits. - Data showed that HIV diagnoses among heterosexual women and men have not declined sufficiently and must decrease to meet elimination targets. - The study team identified gaps: suboptimal uptake of **PrEP**, need for HIV testing innovations, and a case for routine “opt-out” screening in sentinel settings. - Authors observed that HIV-related stigma remains a barrier to prevention and to the wellbeing of people with HIV. - With five years remaining to reach the 2030 elimination target, the paper outlines opportunities, proposes initiatives and reflects on conditions required for success. - The viewpoint synthesises epidemiological and behavioural surveillance, policy responses and community experiences; it is framed as an assessment rather than new primary data. - The authors disclosed funding sources and advisory group participation relevant to surveillance and modelling work in New Zealand.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43056630/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43056630%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43056630/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43056630/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43056630/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43056630/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43056630/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43056630/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43056630%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43056630%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43056630/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43056630/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43056630/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43056630/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43056630/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43056630/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43056630/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/43056630/#conflict-of-interest) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/43056630/#mesh-terms) * [ Grants and funding ](https://pubmed.ncbi.nlm.nih.gov/43056630/#grants) Title & authors Abstract Conflict of interest statement MeSH terms Grants and funding N Z Med J Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22N+Z+Med+J%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22N+Z+Med+J%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056630/) . 2026 Nov 20;139(1646):88-96. doi: 10.26635/6965.7595. # Progress on eliminating New Zealand's HIV epidemic by 2030: successes and opportunities [Peter Saxton](https://pubmed.ncbi.nlm.nih.gov/?term=Saxton+P&cauthor_id=43056630)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43056630/#full-view-affiliation-1 "Director, Gay Men's Sexual Health research group, Waipapa Taumata Rau | The University of Auckland, Auckland; Associate Professor, School of Population Health, Waipapa Taumata Rau | The University of Auckland, Auckland."), [Susan McAllister](https://pubmed.ncbi.nlm.nih.gov/?term=McAllister+S&cauthor_id=43056630)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43056630/#full-view-affiliation-2 "Leader, HIV Epidemiology Group, Department of Public Health, University of Otago, Dunedin.") Affiliations Expand ### Affiliations * 1 Director, Gay Men's Sexual Health research group, Waipapa Taumata Rau | The University of Auckland, Auckland; Associate Professor, School of Population Health, Waipapa Taumata Rau | The University of Auckland, Auckland. * 2 Leader, HIV Epidemiology Group, Department of Public Health, University of Otago, Dunedin. * PMID: **43056630** * DOI: [ 10.26635/6965.7595 ](https://doi.org/10.26635/6965.7595) Item in Clipboard # Progress on eliminating New Zealand's HIV epidemic by 2030: successes and opportunities Peter Saxton et al. N Z Med J. 2026. Show details Display options Display options Format Abstract PubMed PMID N Z Med J Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22N+Z+Med+J%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22N+Z+Med+J%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056630/) . 2026 Nov 20;139(1646):88-96. doi: 10.26635/6965.7595. ### Authors [Peter Saxton](https://pubmed.ncbi.nlm.nih.gov/?term=Saxton+P&cauthor_id=43056630)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43056630/#short-view-affiliation-1 "Director, Gay Men's Sexual Health research group, Waipapa Taumata Rau | The University of Auckland, Auckland; Associate Professor, School of Population Health, Waipapa Taumata Rau | The University of Auckland, Auckland."), [Susan McAllister](https://pubmed.ncbi.nlm.nih.gov/?term=McAllister+S&cauthor_id=43056630)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43056630/#short-view-affiliation-2 "Leader, HIV Epidemiology Group, Department of Public Health, University of Otago, Dunedin.") ### Affiliations * 1 Director, Gay Men's Sexual Health research group, Waipapa Taumata Rau | The University of Auckland, Auckland; Associate Professor, School of Population Health, Waipapa Taumata Rau | The University of Auckland, Auckland. * 2 Leader, HIV Epidemiology Group, Department of Public Health, University of Otago, Dunedin. * PMID: **43056630** * DOI: [ 10.26635/6965.7595 ](https://doi.org/10.26635/6965.7595) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Aotearoa New Zealand has the tools to end human immunodeficiency virus (HIV) transmission and the strategic framework to deliver it. In this viewpoint, we assess progress on the Government's HIV action plan 2023-2030, combining insights from epidemiological and behavioural surveillance, policy responses and the experiences of affected communities. New HIV diagnoses have declined markedly among gay, bisexual and other men who have sex with men (GBM), echoing an increase in HIV prevention behaviours. HIV diagnoses remain very low in key populations such as sex workers and people who inject drugs. These encouraging results show that investing in prevention-technologies and environments-is working. However, HIV diagnoses are static among Māori and Pacific GBM, and must decrease among heterosexual women and men, indicating that the benefits are uneven. With 5 years left to meet the HIV elimination target, we identify gaps and emerging challenges, highlight opportunities, propose new initiatives and reflect on the conditions for success. More can be done to improve HIV pre-exposure prophylaxis (PrEP) uptake, HIV testing innovations are needed and routine "opt-out" HIV screening is warranted in sentinel settings. HIV stigma needs to be eliminated to improve the lives of people with HIV and remove barriers to prevention. © PMA. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement PS receives funding from Health New Zealand – Te Whatu Ora for HIV behavioural surveillance and prevalence modelling and from Burnett Foundation Aotearoa for an unrestricted research fellowship at The University of Auckland. PS participates on the Ministry of Health – Manatū Hauora Sexually Transmitted and Blood Borne Infection Technical Advisory Group. SM receives funding from the Ministry of Health – Manatū Hauora for HIV epidemiological surveillance and prevalence modelling. SM participates on the Ministry of Health – Manatū Hauora Sexually Transmitted and Blood Borne Infection Technical Advisory Group. ## MeSH terms * Epidemics* / prevention & control Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Epidemics%2Fprevention+and+control%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Epidemics) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056630/) * Female Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Female%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Female) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056630/) * HIV Infections* / epidemiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22HIV+Infections%2Fepidemiology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=HIV+Infections) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056630/) * HIV Infections* / prevention & control Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22HIV+Infections%2Fprevention+and+control%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=HIV+Infections) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056630/) * Health Policy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Health+Policy%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Health+Policy) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056630/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056630/) * Male Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Male%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Male) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056630/) * New Zealand / epidemiology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22New+Zealand%2Fepidemiology%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=New+Zealand) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056630/) * Pre-Exposure Prophylaxis Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Pre-Exposure+Prophylaxis%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Pre-Exposure+Prophylaxis) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43056630/) ## Grants and funding * [ PS receives funding from Te Whatu Ora for HIV behavioural surveillance and prevalence modelling and from Burnett Foundation Aotearoa for an unrestricted research fellowship at the University of Auckland. SM receives funding from the Ministry of Health for HIV epidemiological surveillance and prevalence modelling. ](https://pubmed.ncbi.nlm.nih.gov/?term=PS+receives+funding+from+Te+Whatu+Ora+for+HIV+behavioural+surveillance+and+prevalence+modelling+and+from+Burnett+Foundation+Aotearoa+for+an+unrestricted+research+fellowship+at+the+University+of+Auckland.+SM+receives+funding+from+the+Ministry+of+Health+for+HIV+epidemiological+surveillance+and+prevalence+modelling.%5BGrants+and+Funding%5D&sort=date&sort_order=desc "All articles for grant PS receives funding from Te Whatu Ora for HIV behavioural surveillance and prevalence modelling and from Burnett Foundation Aotearoa for an unrestricted research fellowship at the University of Auckland. SM receives funding from the Ministry of Health for HIV epidemiological surveillance and prevalence modelling.") [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM **Send To** * [Clipboard](https://pubmed.ncbi.nlm.nih.gov/43056630/) * [Email](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43056630%2F%23open-email-panel) * [Save](https://pubmed.ncbi.nlm.nih.gov/43056630/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43056630%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43056630%2F%23open-collections-panel) * [Citation Manager](https://pubmed.ncbi.nlm.nih.gov/43056630/) [x] NCBI Literature Resources [MeSH](https://www.ncbi.nlm.nih.gov/mesh/) [PMC](https://www.ncbi.nlm.nih.gov/pmc/) [Bookshelf](https://www.ncbi.nlm.nih.gov/books) [Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited. Follow NCBI [ Twitter ](https://twitter.com/ncbi) [ Facebook ](https://www.facebook.com/ncbi.nlm) [ LinkedIn ](https://www.linkedin.com/company/ncbinlm) [ GitHub ](https://github.com/ncbi) [ ](https://ncbiinsights.ncbi.nlm.nih.gov/) [Connect with NLM](https://www.nlm.nih.gov/socialmedia/index.html) * [ Twitter ](https://twitter.com/NLM_NIH) * [ SM-Facebook ](https://www.facebook.com/nationallibraryofmedicine) * [ SM-Youtube ](https://www.youtube.com/user/NLMNIH) National Library of Medicine [8600 Rockville Pike Bethesda, MD 20894](https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323) [Web Policies](https://www.nlm.nih.gov/web_policies.html) [FOIA](https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office) [HHS Vulnerability Disclosure](https://www.hhs.gov/vulnerability-disclosure-policy/index.html) [Help](https://support.nlm.nih.gov/?pagename=pubmed%3Apubmed%3Aabstract%3ANONE) [Accessibility](https://www.nlm.nih.gov/accessibility.html) [Careers](https://www.nlm.nih.gov/careers/careers.html) * [NLM](https://www.nlm.nih.gov/) * [NIH](https://www.nih.gov/) * [HHS](https://www.hhs.gov/) * [USA.gov](https://www.usa.gov/)
## Related Clinical Research

- [Innate immune states linked to different serological responses after syphilis treatment](https://medichelpline.com/clinical-feed/biorxiv-3-distinct-innate-immune-states-associate-with-divergent-serological-outcomes.md)
- [Methamphetamine reshapes immune cell and plasma signatures in people with HIV](https://medichelpline.com/clinical-feed/medrxiv-14-methamphetamine-use-reshapes-cellular-and-plasma-immune-signatures-in-a-lineage.md)
- [EmERGE mHealth for HIV care: sustained patient activation and safety over 3.2 years](https://medichelpline.com/clinical-feed/pubmed-43059328.md) (DOI: 10.1080/25787489.2026.2759372)
- [Whole-exome analysis of HIV-associated genes in the Mizo population, Northeast India](https://medichelpline.com/clinical-feed/pubmed-42542174.md) (DOI: 10.1016/j.gene.2026.150334)
- [Impact of loss to follow-up on 5-year mortality after tuberculosis treatment in São Paulo, Brazil](https://medichelpline.com/clinical-feed/plos-medicine-0-loss-to-follow-up-during-tuberculosis-treatment-and-5-year-mortality-in-brazil.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.